ANDA 62562, held by Apothecon. Amikacin Sulfate.
As of Nov 16, 2026, ANDA 62562 (Amikin), held by Apothecon, was not approved, with 0 approved supplements and 0 published complete response letters.
| AmikinEQ 50MG BASE/ML · injectable;injection | Amikacin Sulfate | Discontinued |
| AmikinEQ 250MG BASE/ML · injectable;injection | Amikacin Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters